Thursday 26 January 2017 at AstraZeneca Gothenburg

Welcome to join us and your life science colleagues for an open, engaging and informative discussion around the best ways for small life science companies to raise capital to generate big value.

This is part one of a two-part collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. Part two will take place at Sahlgrenska Science Park later in the spring 2017.

ABOUT

Who should attend?

This event is intended for anyone interested in biotech and life science company funding.

An open session featuring presentations and a panel discussion will provide useful insights on the best ways for small life science companies to raise capital to generate big value.

After a networking opportunity and buffet dinner, Nasdaq will host a more intimate surgery session for companies who want to learn more about the practicalities of a stock listing.

Main topics
  • Latest trends in life science funding.
  • The best ways for small companies to raise capital to generate big value.
  • Inside the head of a life science investor.
  • Taking life science to the stock market. The if. The why. The how.
  • Cellink’s breathtaking journey from the lab to the stock market.
  • Practical advice when considering a stock listing.

PROGRAMME

3.00 – 3:30 pm Coffee and Registration
3:30 – 3:35 pm Welcome and introduction
3.35 – 3:45 pm Analysis: latest trends in biotech funding

Adam Kostyal heads up European listings for Nasdaq. Adam keeps tabs on initial public offering (IPO) candidates and helps them figure out when and where to list and how they can prepare. In his presentation, Adam will walk us through the latest trends in biotech funding and help us tap into the know-how and practical experience Nasdaq has gained since it was founded 45 years ago.
3.45 – 4:05 pm Keynote interview – Inside the head of a life science investor

Carl Bennet AB (CBAB) was founded in 1989. The company is the main shareholder in the listed companies Getinge AB, Lifco AB and Elanders AB. In a compelling interview format, Carl Bennet will provide insights on investment decision making and his role to support companies with knowledge and funding, enabling them to continue to develop within their respective areas.
4.05 – 5:00 pm Panel discussion:
What’s the best way for a small life science company to raise capital to generate big value?

“From nothing to a super IPO in only 10 months” – Erik Gatenholm will talk about the incredible journey 3D bioprinting start-up, Cellink, has experienced since it was founded at the beginning of 2016. Johannes Hulthe, CEO for fast-growing medical imaging company, Antaros Medical, will provide an additional start-up perspective. Their experiences from day-to-day decision-making about the best way to fund their respective companies will be combined and contrasted with input from business developers working with companies at Sahlgrenska Science Park, GU Ventures and the AstraZeneca BioVentureHub. Nasdaq and Vator Securities will also provide their perspectives on the best ways for small companies to raise capital. It promises to be an engaging and informative discussion.
5.00 – 6:00 pm NASDAQ Closing Bell Ceremony, with networking and light dinner

Take the opportunity to mingle with and learn from life science colleagues – and the famous Nasdaq bell will toll!
6.00 – 7:30 pm Nasdaq surgery session

Advisers from Nasdaq Nordic – a leading hub for early stage health care companies in Europe – will be on hand to provide practical guidance on how to prepare for a future listing. They’ll run through the benefits of a listing, e.g. raising capital, quality stamp, visibility, as well as examine the do’s and don’ts during the listing process.

PRESENTERS

We’d love for this to be an interactive event based on dialogue between the presenters and audience.

You’re welcome to let us know in advance if there are any particular topics or questions you’d like to ask any of the presenters/panelists. Send us an email at bioventurehub@astrazeneca.com.

And, of course, feel free to ask lots of questions at the event.

REGISTRATION

To register for the event, please click the button below, then fill out and submit the form.

If you have any questions or need to unregister, please contact us via email as soon as possible.

Register here

PRACTICAL INFORMATION

CONTACT

We’d love to hear from you. Feel free to contact us.

 

Email: bioventurehub@astrazeneca.com

Phone: +46 31 776 10 00
(AstraZeneca R&D Gothenburg)

Please ask for:
Karin Angelin Krefting
Jennie Holmstedt